Status
Acquired by Novartis on December 23, 2009
Funding Received
$23 Million in 1 Round from 3 Investors
Headquarters:
San Carlos, CA
Description:
Corthera is engaged in acquiring, developing and commercializing therapies for illnesses in the acute care setting.
Categories:
Biotechnology
Website:
http://www.corthera.com

Company Details

Update

Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera’s lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    150 Industrial Road

    c/o Novartis

    San Carlos, CA 94070

    USA

Images (1)

Update
  • 14f67df119cc01c6f5a86f4f5ff52f7e